Vanguard Group Inc

13F Holdings History for SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO)

Symbol: STRO on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 4.12M shares
Security Ownership: 4.87%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in SUTRO BIOPHARMA, INC. Common Stock, par value $0.001 per share (STRO)

2025-07-29 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.12M shares of SUTRO BIOPHARMA, INC. Common Stock, par value $0.001 per share (STRO). This represents 4.87% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	4.87%		$3.58M	4.12M			$0.87	13G/A	6/30/2025	29 Jul 2025 14:41:07

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0%	0%	$3.2M	3.68M	-432,264	-10.5%	$0.87	Q3 2025
6/30/2025	0%	0%	$2.94M	4.12M	-279,994	-6.37%	$0.71	Q2 2025
3/31/2025	0%	+0%	$2.86M	4.4M	+186,744		$0.65	Q1 2025
12/31/2024	0%		$7.74M	4.21M	+13,428	+0.32%	$1.84	Q4 2024
9/30/2024	0%	+0%	$14.5M	4.2M	+639,732	+18%	$3.46	Q3 2024
6/30/2024	0%	+0%	$10.4M	3.56M	+532,550	+17.6%	$2.93	Q2 2024
3/31/2024	0%	+0%	$17.1M	3.02M	+132,790	+4.59%	$5.65	Q1 2024
12/31/2023	0%	+0%	$12.4M	2.89M	+21,238	+0.74%	$4.29	Q4 2023
9/30/2023	0%	+0%	$9.95M	2.87M	+38,854	+1.37%	$3.47	Q3 2023
6/30/2023	0%	+0%	$13.2M	2.83M	+52,946	+1.91%	$4.65	Q2 2023
3/31/2023	0%	+0%	$12.8M	2.78M	+132,290	+5%	$4.62	Q1 2023
12/31/2022	0%	+0%	$21.4M	2.64M	+594,396	+29%	$8.08	Q4 2022
9/30/2022	0%	+0%	$11.4M	2.05M	+12,951	+0.64%	$5.55	Q3 2022
6/30/2022	0%	0%	$10.6M	2.04M	-193,672	-8.68%	$5.21	Q2 2022
3/31/2022	0%	+0%	$18.3M	2.23M	+113,190	+5.34%	$8.22	Q1 2022
12/31/2021	0%	+0%	$31.5M	2.12M	+2,776	+0.13%	$14.88	Q4 2021
9/30/2021	0%	+0%	$40M	2.12M	+51,836	+2.51%	$18.89	Q3 2021
6/30/2021	0%	+0%	$38.4M	2.06M	+23,206	+1.14%	$18.59	Q2 2021
3/31/2021	0%	+0%	$46.4M	2.04M	+116,370	+6.05%	$22.76	Q1 2021
12/31/2020	0%	+0%	$41.8M	1.92M	+623,814	+48%	$21.71	Q4 2020
9/30/2020	0%	+0%	$13.1M	1.3M	+300,840	+30.1%	$10.05^*	Q3 2020
6/30/2020	0%	+0%	$7.75M	999K	+620,834	+164%	$7.76	Q2 2020
3/31/2020	0%	+0%	$3.86M	378K	+37,544	+11%	$10.20	Q1 2020
12/31/2019	0%	+0%	$3.75M	341K	+17,288	+5.35%	$11.00	Q4 2019
9/30/2019	0%	+0%	$2.94M	323K	+128,045	+65.6%	$9.09	Q3 2019
6/30/2019	0%	+0%	$2.22M	195K	+18,482	+10.5%	$11.38	Q2 2019
3/31/2019	0%	+0%	$2.01M	177K	+52,489	+42.2%	$11.39	Q1 2019
12/31/2018	0%	+0%	$1.12M	124K	+124,283	NEW	$9.02	Q4 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.